MYL9 and type 2 diabetes mellitus: This analysis revealed that zinc-alpha-2-glycoprotein(AZGP1) and myosin regulatory light chain 1 (ORM2) were consistently upregulated in the T2D group acrossmost studies, whereas apolipoprotein A-I (APOA1)was generally downregulated in the T2D group (Figure E, Supporting Information 3).